OR WAIT null SECS
May 02, 2012
How niche strategies can offer mainstream potential for biopharmaceutical companies.
April 02, 2012
Collaboration can begin with a conversation.
Failure to disclose info may work sometimes, but eventually every question will be answered.
The importance of new drug trials to patients, the economy, and science.
March 02, 2012
In a world where product recalls can mean the end of a company, all batches must be perfect.
SOCMA's Bulk Pharmaceuticals Task Force outlines key goals and challenges for user-fee legislation.
Has the long-awaited guidance answered all of the industry's questions?
March 01, 2012
Traditionally more prevalent in less industrialised regions, counterfeit medicines are now more frequently entering the heavily regulated supply chains of EU countries.
February 02, 2012
Pharma announces plans for the year ahead at annual JPMorgan Global Healthcare conference.
A nickel's worth of free advice to the competition could come at the expense of your bottom line.